痴呆症护理研究和心理社会因素
1FLENI, Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
克鲁茨菲尔特-雅各布病 (CJD) 的生存率为7个月. 抗精神病使用可能会减少CJD患者的生存时间,而其他治疗方法没有显著的影响.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 子疾病是子疾病.
背景情况:
- 克鲁茨菲尔特-雅各布病 (CJD) 是一种罕见的,致命的神经退行性疾病,是由子引起的.
- 散发性CJD占90%的病例,表现为痴呆症,无氧症和肌细胞结核.
- 目前,没有有效的治疗方法,平均存活时间为5个月.
研究的目的:
- 分析克鲁茨菲尔特-雅各布病的预后和治疗因素.
- 确定阿根廷CJD患者的生存时间和影响因素.
主要方法:
- 64名CJD患者的医疗记录 (2006-2021) 的回顾性审查.
- 收集的数据包括人口统计,症状,神经成像,EEG,生物标志物,治疗和生存率.
- 世卫组织的诊断标准用于CJD诊断.
主要成果:
- 患有CJD的患者的中位生存期为7个月.
- 经典和认知变体是最常见的 (每一个为28%).
- 葡萄糖皮质醇治疗对生存没有显著影响;抗精神病药物与生存率降低有关.
结论:
- 这个队列中CJD的中位生存时间为7个月.
- 抗精神病药物的使用可能会对CJD患者的存活率产生负面影响.
- 需要进一步的研究来了解CJD的预后和治疗因素.
更多相关视频
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
4.3K
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
14.1K
相关概念视频
Dementia
482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
482
Psychological and Sociocultural Causes of Schizophrenia
438
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
438
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Cognitive Development During Adulthood
740
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
740
Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K
